H
HyperSpectral
AI-powered, hardware agnostic spectral intelligence solution to identify pathogens such as listeria in food-processing environments
About HyperSpectral
HyperSpectral.ai is at the forefront of revolutionizing pathogen detection through its advanced technology that combines spectroscopy and artificial intelligence (AI). The company primarily serves clients in the healthcare and food safety industries, offering a unique solution for identifying dangerous pathogens such as E. coli, salmonella, listeria, and staph aureus in near real-time. By leveraging large, customized datasets, HyperSpectral.ai's platform can recognize different particle spectroscopy signatures, providing faster and more cost-effective results compared to traditional methods.
Operating in the intersection of AI and spectroscopy, HyperSpectral.ai addresses a critical need for more efficient and accurate detection of contaminants. The business model revolves around providing a subscription-based service to its clients, ensuring continuous access to its cutting-edge technology and regular updates. Revenue is generated through these subscriptions as well as potential partnerships and licensing agreements with industry stakeholders.
The market for HyperSpectral.ai's services is vast, encompassing not only healthcare and food safety but also other sectors that require precise and rapid pathogen detection. The company's innovative approach positions it well to expand into new markets and applications in the future.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Alexandria, United States
- Employees
- 31
- Open positions
- 1
- Dealroom signal
- 70.9/100
- Industry
- Health, Food
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, DT and LS, science-based
- Technology
- Artificial Intelligence, Hardware
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Oct 2025 | $7M | $43M | Kibo Ventures · RRE Ventures · Avalanche Thinking | ↗ |
| SERIES AOther financing | Jun 2024 | $8.5M | $34M | Correlation Ventures · GC&H Investments · RRE Ventures · Kibo Ventures | ↗ |
Growth signals
Latest recorded traffic for HyperSpectral is 1.4K monthly website visits, down 33.3% over the last three months. HyperSpectral's team declined 3.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
RRE Ventures
Kibo Ventures
Correlation Ventures- GIGC&H Investments
- ATAvalanche Thinking
Other known investors1 additional known investor
Garrett Gilbertson.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about HyperSpectral on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See HyperSpectral’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.